Drug intelligence / Profile preview

Daylong

Development stage
Preclinical
Lead developer
Galderma
Modality
Small Molecules
Administration
Topical
01

Overview

Daylong is a brand of dermatological sunscreen products, originally developed by Spirig Pharma and later acquired by Galderma. These products are formulated as liposomal lotions, gels, or fluids, providing broad-spectrum protection against UVA, UVB, and sometimes infrared (IR) radiation. They are designed for various skin types, including sensitive skin, and are characterized by high SPF, water resistance, and photostability. Daylong sunscreens often incorporate moisturizing and nourishing ingredients such as aloe vera and vitamin E, and are indicated for preventing sun-induced skin damage, photoaging, and reducing the risk of skin cancer.

Brand names
DaylongDaylong Crème-Gel Légère Spf 50+Daylong Extreme Sun Lotion SPF 50+Daylong Multi Protection Fluid For Face SPF 50+Daylong Extreme Liposomal Sun Milk Spf 50+Daylong Cetaphil Sun SPF50+ Liposomal LotionDaylong Cetaphil Sensitive SPF30 Gel-SprayDaylong Cetaphil Sensitive SPF50+Daylong Cetaphil Sun SPF50 Multi-Protection FluidDaylong Cetaphil Sun Sensitive Gel Fluid SPF50+

Beyond the preview

Go deeper on Daylong.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Daylong.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call